Autism Spectrum Disorder Trial, Recruiting (NCT05916430)

Autism Spectrum Disorder Trial, Recruiting NCT05916430 Sponsor: Emory University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT05916430 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The baby must be between 8 and 10 months old (based on their actual birth date, not adjusted age).
The baby should be generally healthy, with no current illness that could interfere with the study (for example, no vomiting, high fever, or eye infection affecting their vision).
The baby's parent or caregiver must be able to understand the study information and be willing to sign a consent form agreeing to take part.

Who may not be able to join:

Babies who are currently showing signs of an illness that could affect the study results may not be able to take part — for example, if they have an eye infection affecting their vision, are currently vomiting, or have a high fever.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Warren R Jones, PhD, Emory University

Phone: 404-785-4529

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05916430

Sponsor: Emory University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 404-785-4529

More information: https://clinicaltrials.gov/study/NCT05916430

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The baby must be between 8 and 10 months old (based on their actual birth date, not adjusted age).
The baby should be generally healthy, with no current illness that could interfere with the study (for example, no vomiting, high fever, or eye infection affecting their vision).
The baby's parent or caregiver must be able to understand the study information and be willing to sign a consent form agreeing to take part.

Who may not be able to join:

Babies who are currently showing signs of an illness that could affect the study results may not be able to take part — for example, if they have an eye infection affecting their vision, are currently vomiting, or have a high fever.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Emory University

Registry

ClinicalTrials.gov

Start date

2 February 2023

Est. completion

1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accuracy of eye-tracking assays at 9 months relative to ASD vs. non-ASD diagnosis at 24 months; Accuracy of eye-tracking assays at 9 months relative to Affected (ASD or DD) vs. Unaffected status at 24 months.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov